Research and experimental development on natural sciences and engineering
CYTOVATION ASA
Operating profit
NOK −54.8m
Equity
NOK −93.3m
Incorporated
2001
Share capital
NOK 9.3m
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating costs | 54.8m | |
| Operating profit (EBIT) | −54.8m | |
| Net financial items | −8.1m | |
| Profit for the year | −62.9m |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 15.8m | |
| of which current assets | 15.5m | |
| Equity | −93.3m | |
| Total liabilities | 109.1m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.